Deepak Nitrite Limited — Investor Meet, 21-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

1. **Financial Performance**: Deepak Nitrite reported revenues of Rs. 1,924 crore for Q3 FY25, down 5% year-over-year (YoY) and 6% sequentially, primarily due to reduced demand in agrochemical intermediates and a scheduled plant shutdown affecting the Phenolics segment. EBITDA also declined significantly to Rs. 190 crore from Rs. 318 crore YoY, translating to a reduced EBITDA margin. PBT stood at Rs. 135 crore, and PAT was Rs. 98 crore. The Advanced Intermediates segment witnessed an 18% decline in revenues, affected by destocking by international customers, while the Phenolics segment showed some resilience with revenue stability YoY despite production losses.

2. **Future Outlook and Growth Drivers**: Management expects a recovery driven by improved demand across segments, particularly in advanced intermediates, with an anticipated upturn in customer activity starting in Q4 FY25. They highlighted strategic projects, including the commissioning of a new nitric acid complex and a focus on delivering innovative products that will contribute positively to performance in H1 FY26.

3. **Order Book and Operational Updates**: Significant projects underway include the commissioning of the nitric acid complex, expected to enhance self-reliance in critical raw materials. The company is also progressing with various expansions, with estimates suggesting capex for the nitric acid plant could yield an annual margin expansion of Rs. 70-80 crore.

4. **Analyst Q&A Insights (Detailed)**:

- **Revenue and Profitability**: Analysts queried the impact of deferring sales particularly from agrochemical intermediates; management acknowledged that while volumes were down, there is visible recovery expected in Q4.

- **Market Position and Competitive Landscape**: Analysts expressed concerns about competitive pricing pressures and market share. Management reassured that with domestic capacity surging, they anticipate regaining market footing and improved profitability.

- **Operational Challenges or Risks**: Concerns regarding raw material costs and supply chain risks were raised. The management expressed confidence in their diversified sourcing strategies mitigating these risks effectively.

- **Capex and Capital Allocation**: Analysts inquired about future capex amidst market stress. The management confirmed maintained capex plans aiming for integrated facility advantages.

- **Strategic Priorities and Long-Term Vision**: Questions focused on the expected timelines for various projects. Management reiterated an integrated approach to future capacity additions, stressing synergy across operational timelines.

5. **Market or Regulatory Updates**: The call touched on investigations into the dumping of certain products by the Indian government, potentially impacting the market dynamics for dye intermediates.

6. **Strategic Focus Areas**: The call revealed a clear strategic emphasis on innovation, sustainability, and improved operational efficiency through integrated facilities. Management's optimism about the performance recovery aligns with broader market trends showing an uptick in demand.

7. **Investor Insight**: Given the present financial health characterized by solid portfolio growth potential and strategic expansions, the favorable outlook suggests a ‘buy’ position pending execution of the recovery strategies discussed in the call. However, potential volatility in raw material prices must be considered as a cautious note moving forward.